On May 23, 2024, Jared Isaacman, Chairman & Chief Executive Officer and 10% Owner of Shift4 Payments Inc (NYSE:FOUR), purchased 39,135 shares of the company.
On May 21, 2024, Robert Waltermire, Senior Vice President and Chief Pharmaceutical Development Officer at Madrigal Pharmaceuticals Inc (NASDAQ:MDGL), sold 1,036 shares of the company.